UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

Clinical cancer research, 2018-12, Vol.24 (24), p.6185-6194

2018

Volltextzugriff (PDF)

Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Bone marrow transplantation (Basingstoke), 2019-06, Vol.54 (6), p.798-809

2019

Volltextzugriff (PDF)

Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia

Pediatric blood & cancer, 2018-10, Vol.65 (10), p.e27300-n/a

2018

Volltextzugriff (PDF)

Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia

Leukemia, 2024-04, Vol.38 (4), p.712-719

2024

Volltextzugriff (PDF)

Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol

Cancer, 2006-10, Vol.107 (7), p.1551-1561

2006

Volltextzugriff (PDF)

Impact of body mass index on outcome and treatment-related toxicity in young adults with acute lymphoblastic leukemia

Acta oncologica, 2023, Vol.62 (12), p.1723-1731

2023

Volltextzugriff (PDF)

Hematopoietic Stem Cell Transplantation Rates and Long-Term Survival in Acute Myeloid and Lymphoblastic Leukemia: Real-World Population-Based Data From the Swedish Acute Leukemia Registry 1997-2006

Cancer, 2011-09, Vol.117 (18), p.4238-4246

2011

Volltextzugriff (PDF)

Real-world data on first relapse of acute lymphoblastic leukemia in patients >55 years

Leukemia & lymphoma, 2018-10, Vol.59 (10), p.2470-2473

2018

Volltextzugriff (PDF)

The prophylactic use of granulocyte-colony stimulating factor during remission induction is associated with increased leukaemia-free survival of adults with acute lymphoblastic leukaemia: A joint analysis of five randomised trials on behalf of the EWALL

European journal of cancer (1990), 2012-02, Vol.48 (3), p.360-367

2012

Volltextzugriff (PDF)

Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia

Leukemia, 2018-03, Vol.32 (3), p.606-615

2018

Volltextzugriff (PDF)

Long-term outcome of Epstein-Barr virus DNAemia and PTLD with the use of preemptive rituximab following allogeneic HSCT

Leukemia & lymphoma, 2018-05, Vol.59 (5), p.1172-1179

2018

Volltextzugriff (PDF)

Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?

Leukemia & lymphoma, 2012-09, Vol.53 (9), p.1699-1705

2012

Volltextzugriff (PDF)

Parental Age, Family Size, and Offspring's Risk of Childhood and Adult Acute Leukemia

Cancer epidemiology, biomarkers & prevention, 2012-07, Vol.21 (7), p.1185-1190

2012

Volltextzugriff (PDF)

High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden: graft-versus-leukemia effect protects against relapse

Medical oncology (Northwood, London, England), 2013-12, Vol.30 (4), p.762-762, Article 762

2013

Volltextzugriff (PDF)

Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting

Leukemia, 2021-07, Vol.35 (7), p.1894-1906

2021

Volltextzugriff (PDF)

T-cell acute lymphoblastic leukemia in patients 1-45 years treated with the pediatric NOPHO ALL2008 protocol

Leukemia, 2020-02, Vol.34 (2), p.347-357

2020

Volltextzugriff (PDF)

Does granulocyte colony-stimulating factor improve long-term outcome in adult acute lymphoblastic leukemia?

Leukemia & lymphoma, 2009-11, Vol.50 (11), p.1872-1874

2009

Volltextzugriff (PDF)

Satisfactory outcome after intensive chemotherapy with pragmatic use of minimal residual disease (MRD) monitoring in older patients with Philadelphia-negative B cell precursor acute lymphoblastic leukaemia: a Swedish registry-based study

Medical oncology (Northwood, London, England), 2015-04, Vol.32 (4), p.135-135, Article 135

2015

Volltextzugriff (PDF)

Long-term survival following allogeneic or syngeneic stem cell transplant for follicular lymphoma in Sweden

Leukemia & lymphoma, 2011-01, Vol.52 (1), p.69-71

2011

Volltextzugriff (PDF)

Allogeneic haematopoietic stem-cell transplantation with reduced intensity conditioning for advanced stage Hodgkin's lymphoma in Sweden: high incidence of post transplant lymphoproliferative disorder

Bone marrow transplantation (Basingstoke), 2011-06, Vol.46 (6), p.870-875

2011

Volltextzugriff (PDF)

Outcome after HSCT in Philadelphia chromosome positive acute lymphoblastic leukemia in Sweden: a population-based study

Medical oncology (Northwood, London, England), 2014, Vol.31 (8), p.66-66, Article 66

2014

Volltextzugriff (PDF)

Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience

Bone marrow transplantation (Basingstoke), 2005-06, Vol.35 (12), p.1141-1148

2005

Volltextzugriff (PDF)

In vitro activity of imatinib in cells from patients with adult acute lymphoblastic leukemia

Anti-cancer drugs, 2005-07, Vol.16 (6), p.631-634

2005

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia

Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia

Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol

Impact of body mass index on outcome and treatment-related toxicity in young adults with acute lymphoblastic leukemia

Hematopoietic Stem Cell Transplantation Rates and Long-Term Survival in Acute Myeloid and Lymphoblastic Leukemia: Real-World Population-Based Data From the Swedish Acute Leukemia Registry 1997-2006

Real-world data on first relapse of acute lymphoblastic leukemia in patients >55 years

The prophylactic use of granulocyte-colony stimulating factor during remission induction is associated with increased leukaemia-free survival of adults with acute lymphoblastic leukaemia: A joint analysis of five randomised trials on behalf of the EWALL

Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia

Long-term outcome of Epstein-Barr virus DNAemia and PTLD with the use of preemptive rituximab following allogeneic HSCT

Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?

Parental Age, Family Size, and Offspring's Risk of Childhood and Adult Acute Leukemia

High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden: graft-versus-leukemia effect protects against relapse

Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting

T-cell acute lymphoblastic leukemia in patients 1-45 years treated with the pediatric NOPHO ALL2008 protocol

Does granulocyte colony-stimulating factor improve long-term outcome in adult acute lymphoblastic leukemia?

Satisfactory outcome after intensive chemotherapy with pragmatic use of minimal residual disease (MRD) monitoring in older patients with Philadelphia-negative B cell precursor acute lymphoblastic leukaemia: a Swedish registry-based study

Long-term survival following allogeneic or syngeneic stem cell transplant for follicular lymphoma in Sweden

Allogeneic haematopoietic stem-cell transplantation with reduced intensity conditioning for advanced stage Hodgkin's lymphoma in Sweden: high incidence of post transplant lymphoproliferative disorder

Outcome after HSCT in Philadelphia chromosome positive acute lymphoblastic leukemia in Sweden: a population-based study

Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience

In vitro activity of imatinib in cells from patients with adult acute lymphoblastic leukemia

Aktive Filter

Suchergebnisse filtern